VITALISScE™ Study
Living with scleroderma?
If you are living with scleroderma, joining the VITALISScE™ study might be a suitable option for you.
The VITALISScE™ study is looking at an investigational medicine called BI 685509 as a potential treatment for people who have systemic sclerosis (scleroderma).
You may be able to participate if you:
- Are 18 years of age or older
- Have been diagnosed with systemic sclerosis in the past 7 years
- Are dealing with worsening of skin thickening or if your condition has spread to new areas
of your body
Other requirements will need to be met to take part in the study.
Participants in the VITALISScE™ study (also known as clinical trial 1366-0031) will be joining a global effort to find better choices for treatment in the future for people living with scleroderma.
Taking part in the VITALISScE™ study is free and you may receive reimbursement for study-related expenses (for example, travel and meals).
Contact VITALISScE™ to find out more:
Study Coordinator: Mindy Mok
Email:mmok4@providencehealth.bc.ca
Phone: 604-806-8117 EXT 68117
Official Study Poster & Brochure: